Sort
48,018 grants matching “immunotherapy”
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,790,298Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,789,540E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2021 · CA
Moffitt Skin Cancer SPORE
$1,789,062Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2017 · CA
Roswell Park Ovarian Cancer SPORE
$1,787,915Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2025 · CA
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,787,333Carl H. June · University Of Pennsylvania · U19 · FY2011 · AI
Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS
$1,786,891Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,786,679Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2009 · CA
Strategies to Overcome Immune Resistance in Head and Neck Cancers
$1,786,322Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2019 · CA
Project 3
$1,786,272Michael C. Milone · University Of Pennsylvania · U54 · FY2019 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,786,066Washington University · U01 · FY2001 · AI
COLORADO ADULT AIDS CLINICAL TRIALS UNIT
$1,785,928University Of Colorado Denver · U01 · FY2001 · AI
Optimizing myeloma-specific immunity after autologous stem cell transplantation
$1,785,659Geoffrey Roger Hill · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Immunohistochemical analysis of tumors
$1,785,509Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids
$1,785,477Zhexing Wen · Emory University · RF1 · FY2025 · AG
Project 2
$1,785,033Gerald P Linette · University Of Pennsylvania · U54 · FY2019 · CA
Vector-pathogen-host interaction and immunopathogenesis of disease progression
$1,784,535Tais B Saito · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
ADULT AIDS CLINICAL TRIALS GROUP
$1,783,212University Of Alabama At Birmingham · U01 · FY2001 · AI
Building on the success of the adoptive immunotherapy of cancer
$1,782,313Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
LENTIVIRUS-BASED IMMUNOTHERAPY FOR AIDS
$1,781,843John A Zaia · Beckman Research Institute/City Of Hope · P01 · FY2007 · AI
EPITHELIAL OVARIAN CANCER PROGRAM PROJECT
$1,781,716Sloan-Kettering Institute For Cancer Res · P01 · FY2002 · CA
First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
$1,777,952Andrew B Norman · University Of Cincinnati · U01 · FY2021 · DA
LENTIVIRUS-BASED IMMUNOTHERAPY FOR AIDS
$1,777,502John A Zaia · Beckman Research Institute/City Of Hope · P01 · FY2006 · AI
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,777,058E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2020 · CA
AIDS CLINICAL TRIALS UNIT
$1,774,934Harvard University (Medical School) · U01 · FY2000 · AI
BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER
$1,774,569Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA